Cargando…

Estimation of treatment effects in weighted log-rank tests

Non-proportional hazards have been observed in clinical trials. The log-rank test loses power and the standard Cox model generally produces biased estimates under such conditions. Weighted log-rank tests have been utilized to increase the test power; however, it is not intuitive how to interpret the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ray S., León, Larry F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898500/
https://www.ncbi.nlm.nih.gov/pubmed/29696204
http://dx.doi.org/10.1016/j.conctc.2017.09.004
_version_ 1783314134442442752
author Lin, Ray S.
León, Larry F.
author_facet Lin, Ray S.
León, Larry F.
author_sort Lin, Ray S.
collection PubMed
description Non-proportional hazards have been observed in clinical trials. The log-rank test loses power and the standard Cox model generally produces biased estimates under such conditions. Weighted log-rank tests have been utilized to increase the test power; however, it is not intuitive how to interpret the test result in terms of the clinical effect. We propose a Cox-model based time-varying treatment effect estimate to complement the weighted log-rank test. The score test from the proposed model is equivalent to the weighted log-rank test, and a time-profile of the treatment effect can be obtained by fitting a time-varying covariate Cox model. Simulation results show that the proposed model preserves type-I error and achieve higher power than log-rank tests under non-proportional hazards scenarios. Whereas the standard Cox model produces biased effect estimates, the proposed model produces unbiased estimates if the weight function is correctly specified. It also achieves a better model fit and an enhanced flexibility to accommodate non-proportional hazards compared to the standard Cox model. The proposed approach makes the assumptions of the weighted log-rank test explicit and the validity of assumptions can be assessed based on prior knowledge or model goodness-of-fit. It also helps to translate the weighted log-rank test results into quantitative estimates of the treatment effect with intuitive interpretation. The proposed method can be routinely conducted to complement weighted log-rank tests, especially in the setting where non-proportional hazards are expected.
format Online
Article
Text
id pubmed-5898500
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-58985002018-04-25 Estimation of treatment effects in weighted log-rank tests Lin, Ray S. León, Larry F. Contemp Clin Trials Commun Article Non-proportional hazards have been observed in clinical trials. The log-rank test loses power and the standard Cox model generally produces biased estimates under such conditions. Weighted log-rank tests have been utilized to increase the test power; however, it is not intuitive how to interpret the test result in terms of the clinical effect. We propose a Cox-model based time-varying treatment effect estimate to complement the weighted log-rank test. The score test from the proposed model is equivalent to the weighted log-rank test, and a time-profile of the treatment effect can be obtained by fitting a time-varying covariate Cox model. Simulation results show that the proposed model preserves type-I error and achieve higher power than log-rank tests under non-proportional hazards scenarios. Whereas the standard Cox model produces biased effect estimates, the proposed model produces unbiased estimates if the weight function is correctly specified. It also achieves a better model fit and an enhanced flexibility to accommodate non-proportional hazards compared to the standard Cox model. The proposed approach makes the assumptions of the weighted log-rank test explicit and the validity of assumptions can be assessed based on prior knowledge or model goodness-of-fit. It also helps to translate the weighted log-rank test results into quantitative estimates of the treatment effect with intuitive interpretation. The proposed method can be routinely conducted to complement weighted log-rank tests, especially in the setting where non-proportional hazards are expected. Elsevier 2017-09-19 /pmc/articles/PMC5898500/ /pubmed/29696204 http://dx.doi.org/10.1016/j.conctc.2017.09.004 Text en © 2017 F. Hoffmann-La Roche Ltd, Genentech Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Lin, Ray S.
León, Larry F.
Estimation of treatment effects in weighted log-rank tests
title Estimation of treatment effects in weighted log-rank tests
title_full Estimation of treatment effects in weighted log-rank tests
title_fullStr Estimation of treatment effects in weighted log-rank tests
title_full_unstemmed Estimation of treatment effects in weighted log-rank tests
title_short Estimation of treatment effects in weighted log-rank tests
title_sort estimation of treatment effects in weighted log-rank tests
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898500/
https://www.ncbi.nlm.nih.gov/pubmed/29696204
http://dx.doi.org/10.1016/j.conctc.2017.09.004
work_keys_str_mv AT linrays estimationoftreatmenteffectsinweightedlogranktests
AT leonlarryf estimationoftreatmenteffectsinweightedlogranktests